CRSP vs PNW · rev $11.6M vs P/E 19, rev $2.61B
Crispr Therapeutics AG (CRSP) versus Pinnacle West Capital Corp (PNW) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
CRSP currently screens at market cap $5.42B. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Not investment advice. Open the CRSP and PNW stock pages for the full models.
Not investment advice.